Zobrazeno 1 - 10
of 28
pro vyhledávání: '"Ulrike Graubner"'
Autor:
Gabriele Escherich, Anja Tröger, Ulrich Göbel, Ulrike Graubner, Arnulf Pekrun, Norbert Jorch, Gjl Kaspers, Martin Zimmermann, Udo zur Stadt, Karin Kazemier, Rob Pieters, Monique L. Den Boer, Martin Horstmann, Gritta E. Janka
Publikováno v:
Haematologica, Vol 96, Iss 6 (2011)
Background In a study of childhood acute lymphoblastic leukemia (CoALL 06-97 study), the in vitro sensitivity of the patients’ cells to prednisolone, vincristine and asparaginase was introduced as a new additional risk parameter for treatment strat
Externí odkaz:
https://doaj.org/article/90bdd4516ab64d82b37e9388534e95f0
Autor:
Gertjan J.L. Kaspers, Ulrich Göbel, Arnulf Pekrun, Rob Pieters, Karin M. Kazemier, Udo zur Stadt, Martin A. Horstmann, Norbert Jorch, Anja Tröger, Martin Zimmermann, Gabriele Escherich, Ulrike Graubner, Monique L. den Boer, Gritta Janka
Publikováno v:
Escherich, G, Troger, A, Gobel, U, Graubner, U, Pekrun, A, Jorch, N, Kaspers, G J L, Zimmermann, M, Stadt, U Z, Kazemier, K, Pieters, R, den Boer, M L, Horstmann, M & Janka, G E 2011, ' The long-term impact of in vitro drug sensitivity on risk stratification and treatment outcome in acute lymphoblastic leukemia of childhood (CoALL 06-97) ', Haematologica, vol. 96, no. 6, pp. 854-862 . https://doi.org/10.3324/haematol.2010.039735
Haematologica, 96(6), 854-862. Ferrata Storti Foundation
Haematologica, 96(6), 854-862. Ferrata Storti Foundation
In a study of childhood acute lymphoblastic leukemia (CoALL 06-97 study), the in vitro sensitivity of the patients' cells to prednisolone, vincristine and asparaginase was introduced as a new additional risk parameter for treatment stratification. In
Autor:
Rob Pieters, Karin M. Kazemier, William E. Evans, Cheng Cheng, Amy Holleman, Meyling Cheok, Renée X. de Menezes, Ulrich Göbel, Gritta Janka-Schaub, Ulrike Graubner, Monique L. den Boer
Publikováno v:
Blood, 107(2), 769-775. American Society of Hematology
Childhood acute lymphoblastic leukemia (ALL) consists of various subtypes that respond differently to cytotoxic drugs and therefore have a markedly different clinical outcome. We used microarrays to investigate, in 190 children with ALL at initial di
Autor:
Meyling Cheok, Deqing Pei, Amy Holleman, Ulrike Graubner, William E. Evans, Karin M. Kazemier, Gritta Janka-Schaub, James R. Downing, Rob Pieters, Monique L. den Boer, Ching-Hon Pui, Ulrich Göbel
Publikováno v:
Blood, 108(6), 1984-1990. American Society of Hematology
New prognostic factors may result in better risk classification and improved treatment of children with acute lymphoblastic leukemia (ALL). Recently, high expression of a gene named OPAL1 (outcome predictor in acute leukemia) was reported to be assoc
Autor:
S. Schulze, Irene Schmid, Rainer Haas, C. Goetz, Daniel Stachel, R. Elsner, Ulrike Graubner, B. Pöllinger
Publikováno v:
Klinische Pädiatrie. 217:153-157
Supratentorial primitive neuroectodermal tumors (stPNETs) are malignant tumors. We saw within three years six children with stPNETs. In four of the six children radical resection could be achieved. All had craniospinal irradiation and chemotherapy ac
Autor:
Heinrich Frauenknecht, Sabine Rössler, Inken Schneider, Claudia Goetz, Anja Golbeck, Dieter Sackerer, Irene Schmid, Ulrike Graubner, Karl Bise, Hans-Peter Asmuss, Uta Behrends, Stephan Müller-Weihrich, Manfred Späth, Josef Mautner, Gerhard Eigenstetter, Brigitte Lechner, Franz Prantl, Colette Zobywalski
Publikováno v:
International Journal of Cancer. 106:244-251
Medulloblastoma is an embryonal childhood malignancy with poor prognosis. By screening 4 medulloblastoma cDNA expression libraries (SEREX) with autologous sera, 15 different antigens were identified. These antigens were encoded by 3 novel genes, gene
Autor:
Günter Henze, Hartmut Kabisch, Martin Zimmermann, Helmut Gadner, Hermann J, Astrid Gnekow, Frank Berthold, Dieter Körholz, P. Imbach, J. Ritter, H.-J. Spaar, U. Creutzig, Dirk Reinhardt, Charlotte M. Niemeyer, A. Reiter, Heribert Jürgens, Ulrike Graubner, Gudrun Fleischhack, Joachim Boos
Publikováno v:
Klinische Pädiatrie. 213:175-185
Background In the multicenter trial AML-BFM 93 daunorubicin or idarubicin was randomly applied in all patients during induction in combination with cytarabine and etoposide. After induction all patients were stratified to the standard or high risk gr
Autor:
Martin Schrappe, Joachim Boos, Bernd H. Belohradsky, H.-J. Spaar, Wolfgang Dörffel, Charlotte M. Niemeyer, Ursula Creutzig, Max Lakomek, Ulrike Graubner
Publikováno v:
Klinische Pädiatrie. 211:347-352
Infections in disease- and/or chemotherapy-related neutropenia are major, often emergency-type problems in the treatment of pediatric oncology patients and explain the ongoing discussion about antiinfectious prophylaxis. The different aspects of prop
Autor:
Birte Hesselbarth, Ulrike Graubner
Cancer is very rare in childhood and adolescence. Thereby, children less than 4 years old suffer mainly from leukaemias, young people from osteosarcoma and Ewing sarcoma. The therapy is made according to the medical standard protocols. In a 5-year su
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5e5bfae7b9a3fbf1abf1996e5212f530
https://doi.org/10.1016/b978-3-437-31602-9.00051-6
https://doi.org/10.1016/b978-3-437-31602-9.00051-6